46 related articles for article (PubMed ID: 32571394)
21. Correction to: Task sharing for the care of severe mental disorders in a low-income country (TaSCS): study protocol for a randomised, controlled, non-inferiority trial.
Hanlon C; Alem A; Medhin G; Shibre T; Ejigu DA; Negussie H; Dewey M; Wissow L; Prince M; Susser E; Lund C; Fekadu A
Trials; 2020 Oct; 21(1):829. PubMed ID: 33023647
[TBL] [Abstract][Full Text] [Related]
22. Correction to: One Plus One Equals Two-will that do? A trial protocol for a Swedish multicentre randomised controlled trial to evaluate a clinical practice to reduce severe perineal trauma.
Edqvist M; Dahlen HG; Häggsgård C; Tern H; Ängeby K; Tegerstedt G; Teleman P; Ajne G; Rubertsson C
Trials; 2020 Dec; 21(1):993. PubMed ID: 33267876
[TBL] [Abstract][Full Text] [Related]
23. Correction to: Persistent physical symptoms reduction intervention: a system change and evaluation in secondary care (PRINCE secondary) - a CBT-based transdiagnostic approach: study protocol for a randomised controlled trial.
Chalder T; Patel M; James K; Hotopf M; Frank P; Watts K; McCrone P; David A; Ashworth M; Husain M; Garrood T; Moss-Morris R; Landau S
BMC Psychiatry; 2020 Aug; 20(1):403. PubMed ID: 32787819
[TBL] [Abstract][Full Text] [Related]
24. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
25. Correction to: Protocol for a randomised controlled trial to investigate the effect of home- and gym-based resistance exercise training on glycaemic control, body composition and muscle strength.
Al Ozairi E; Alsaeed D; Taliping D; Jalali M; El Samad A; Mashankar A; Taghadom E; Guess N; Gill JMR; Sattar N; Gray C; Welsh P; Gray SR
Trials; 2020 Jul; 21(1):650. PubMed ID: 32669132
[TBL] [Abstract][Full Text] [Related]
26. Correction to: IMPROVEjob - Participatory intervention to improve job satisfaction of general practice teams: a model for structural and behavioural prevention in small and medium-sized enterprises - a study protocol of a cluster-randomised controlled trial.
Weltermann BM; Kersting C; Pieper C; Seifried-Dübon T; Dreher A; Linden K; Rind E; Ose C; Jöckel KH; Junne F; Werners B; Schroeder V; Bois JM; Siegel A; Thielmann A; Rieger MA; Kasten S;
Trials; 2020 Dec; 21(1):1004. PubMed ID: 33292423
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
28. Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial.
Malhotra A; Ernest D; Rogers BA; Haylock D; Watt A; Moeneclaey G; Jenkin G
Trials; 2020 Jun; 21(1):474. PubMed ID: 32493459
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
; Gordon AC; Mouncey PR; Al-Beidh F; Rowan KM; Nichol AD; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Berry LR; Bhimani Z; Bonten MJM; Bradbury CA; Brunkhorst FM; Buzgau A; Cheng AC; Detry MA; Duffy EJ; Estcourt LJ; Fitzgerald M; Goossens H; Haniffa R; Higgins AM; Hills TE; Horvat CM; Lamontagne F; Lawler PR; Leavis HL; Linstrum KM; Litton E; Lorenzi E; Marshall JC; Mayr FB; McAuley DF; McGlothlin A; McGuinness SP; McVerry BJ; Montgomery SK; Morpeth SC; Murthy S; Orr K; Parke RL; Parker JC; Patanwala AE; Pettilä V; Rademaker E; Santos MS; Saunders CT; Seymour CW; Shankar-Hari M; Sligl WI; Turgeon AF; Turner AM; van de Veerdonk FL; Zarychanski R; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Webb SA; Derde LPG
N Engl J Med; 2021 Apr; 384(16):1491-1502. PubMed ID: 33631065
[TBL] [Abstract][Full Text] [Related]
30. Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis.
Dahms K; Mikolajewska A; Ansems K; Metzendorf MI; Benstoem C; Stegemann M
Eur J Med Res; 2023 Feb; 28(1):100. PubMed ID: 36841793
[TBL] [Abstract][Full Text] [Related]
31. Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients.
Silva-Aguiar RP; Peruchetti DB; Rocco PRM; Schmaier AH; E Silva PMR; Martins MA; Carvalho VF; Pinheiro AAS; Caruso-Neves C
Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L596-L602. PubMed ID: 32783619
[TBL] [Abstract][Full Text] [Related]
32. Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):536. PubMed ID: 32546220
[TBL] [Abstract][Full Text] [Related]
33. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
[TBL] [Abstract][Full Text] [Related]
34. Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Bosteels C; Maes B; Van Damme K; De Leeuw E; Declercq J; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht BN
Trials; 2020 Jun; 21(1):554. PubMed ID: 32571428
[TBL] [Abstract][Full Text] [Related]
35. Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):641. PubMed ID: 32665001
[TBL] [Abstract][Full Text] [Related]
36. Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht BN
Trials; 2020 Jun; 21(1):556. PubMed ID: 32571394
[TBL] [Abstract][Full Text] [Related]
37. Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod Jessica Justman EA; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Nov; 21(1):927. PubMed ID: 33203476
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
